Advertisement

Asthma

  • Study to test efficacy of tezepelumab for treating asthma exacerbations in the emergency department

    Study to test efficacy of tezepelumab for treating asthma exacerbations in the emergency department

    Diego J. Maselli, MD, FCCP, said the TERAA trial will provide needed evidence on the use of biologics in the acute care setting.


  • Tezepelumab trial demonstrates solid results for treatment of CRSwNP

    Tezepelumab trial demonstrates solid results for treatment of CRSwNP

    Joseph K. Han, MD, said the data showed the highest change in sinonasal outcome test scores from baseline compared with any other biologic studies for chronic rhinosinusitis with nasal polyps.


  • Study demonstrates viability of biologics for severe asthma, COPD exacerbations in eosinophilic inflammation

    Study demonstrates viability of biologics for severe asthma, COPD exacerbations in eosinophilic inflammation

    While larger studies are needed, Dharani K. Narendra, MD, FCCP, said the findings from the ABRA trial could be a game changer and reduce the need for glucocorticoids for some patients.


  • Growing evidence links perinatal exposures and childhood asthma risk

    Growing evidence links perinatal exposures and childhood asthma risk

    Research by Christian Rosas-Salazar, MD, MPH, is improving understanding of mechanisms at play from such exposures as antibiotics, RSV, tobacco smoke, and more.


  • Consequences of wildfire smoke exposure extend beyond local area

    Consequences of wildfire smoke exposure extend beyond local area

    In a recent study, Mary E. Maldarelli, MD, and colleagues demonstrated that wildfires can increase health risks even from thousands of miles away.


  • Mitigating risk of asthma emergencies during respiratory season

    Mitigating risk of asthma emergencies during respiratory season

    During flu season, asthma emergencies become a heightened concern, especially among children. Proactive measures including vaccination, updated asthma action plans, and access to quick relief medications are critical.


  • Making invisible problems visible

    Making invisible problems visible

    For Erika Mosesón, MD, a pulmonologist and ICU doctor, advocacy for clean air and climate action started small: signing petitions and writing letters. Even as she attended conferences and learned about the health impacts of air pollution, her impression was that experts were handling it. “I didn’t really think my voice was worth highlighting,” Dr.…


  • Tackling the massive threat of climate change

    Tackling the massive threat of climate change

    Soon after moving to Pittsburgh for my pulmonary and critical care medicine fellowship in 2014, I began noticing a theme: So many of my patients expressed a sense that the air they breathed was harming them or was in some way responsible for the severity of their lung disease. In this city, the legacy of…